尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the detailed record of transactions filed by Carvajal Alejandra, Directeur Juridique. Director active across 2 companies, notably Mersana Therapeutics, Inc.. Cumulatively, 10 filings have been published. History available since 26 April 2022. The latest transaction was filed on 3 August 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Carvajal Alejandra is Directeur Juridique. She is associated with Mersana Therapeutics, Inc. as SVP, Chief Legal Officer, and with CytomX Therapeutics, Inc. as Chief Legal Officer. The record shows 10 filings in total. Across the 10 sampled filings, the recorded transactions are all option exercises, with a date range from 2022-04-28 to 2026-08-05.